Emory Pathology Research Lab Page: Dr. Keqiang Ye
 

More information on...

  • Home
  • Training
  • Research
  • Clinical Service
  • Expert Consultation
  • Faculty
  • Laboratory of:

    Keqiang Ye, PhD
    Pathology & Laboratory Medicine
    Emory University School of Medicine
    Whitehead Biomedical Building
    Room 145
    615 Michael Street
    Atlanta, GA 30322, USA

    Primary Areas of Research:

    Bioinformatics
    Cancer Biology
    Cardiovascular Research
    Epithelial Cell Biology
    HIV/SIV
    Immunology
    Infectious Diseases
    Oncology/DNA Repair
    Renal Pathology
    Signal Transduction
    Transfusion Medicine

    Dr. Keqiang Ye's Lab Team

    Experimental Pathology Division - Signal Transduction


    Keqiang Ye, PhD

    Primary Laboratory Research:

    - How NGF regulates neuronal cell survival in the nucleus
    My lab is mainly interested in identifying the molecular mechanisms how NGF regulates neuronal cell survival in the nucleus. There are three major research directions: a) identification and characterization of nuclear Akt substrates; b) to dissect the brain specific nuclear GTPase PIKE and characterize its biological functions including its role in human brain tumors; c) NGF-mediated nuclear proteins antagonizing apoptosis. Moreover, we are also interested in determining the biological role of NF2/PIKE signaling in neurofibromatosis II.



    Patents:

    ·Issued: No. 01028 "Noscapine and Noscapine Derivatives, Useful as Anticancer Agent" (60/057/037 and PCT/US98/14979)
    ·Pending: No. 97012 "The Antitissue Drug Noscapine is a Tubulin Binding Anti-Tumor Drug"
    ·Pending: No. 98056 "Use of Anticancer Agent Noscapine, as an immunological Adjuvant for Tumor Therapy"
    ·Pending: No. 02040 "Delivery Systems and Methods for Nocapine and Noscapine Derivatives, Useful as Anticancer Agent"

    Active Grants:

    Federally Funded -
    ·PI, NIH RO1
    Nuclear GTPase PIKE Regulation and Functions.
    RO1 NS045627-01A1; $1,613,800, January 2004-December, 2008
    ·PI, NIH RO1
    The Role of Merlin Phosphorylation on Tumor Suppressive Activity.
    RO1 CA117872-01; $1,702,700; March, 2006-February, 2011
    ·PI, NIH RO1
    Molecular Regulation and Biological Functions of PIKE-A.
    RO1 CA CA127119
    $1,937,500; July 1st, 2008-June 30th, 2013
    ·PI, Department of Defense
    Neurofibromatosis Researcher-Initiated Award
    $1,110,363; February, 2006-January, 2010
    Previous Funding: -
    ·PI, Department of Defense
    Neurofibromatosis New Investigator Award, $554,200
    "Neurofibromatosis 2 Tumor Suppressor, Merlin, Inhibits PIKE/PI 3-Kinase Signaling"
    2003 - 2006
    ·PI, The Sontag Foundation
    Distinguished Young Scientist Award, $500,000
    PIKE-A, a novel GTPase that mediates human brain cancer invasion through regulating Akt
    2003 - 2006
    ·PI, American Cancer Society for Research Scholar, TBE-105131,
    Dissection of the Nuclear GTPase PIKE Signaling, $797,800,
    January 2004 –December 2007
    ·Department of Defense, Neurofibromatosis New Investigator Award ($554,200; 2003 - 2006); PI

    Current Post-doctoral Fellows:

    Previous Postdoc Fellows: